These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34485416)

  • 1. Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure.
    Balogh V; MacAskill MG; Hadoke PWF; Gray GA; Tavares AAS
    Front Cardiovasc Med; 2021; 8():719031. PubMed ID: 34485416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging in heart failure: the role of new tracers.
    Saraste A; Knuuti J
    Heart Fail Rev; 2017 Jul; 22(4):501-511. PubMed ID: 28474327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets.
    Saraste A; Knuuti J; Bengel F
    Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1318-1328. PubMed ID: 37294318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application.
    Tersalvi G; Beltrani V; Grübler MR; Molteni A; Cristoforetti Y; Pedrazzini G; Treglia G; Biasco L
    J Cardiovasc Dev Dis; 2023 May; 10(5):. PubMed ID: 37233187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications.
    Boogers MJ; Fukushima K; Bengel FM; Bax JJ
    Heart Fail Rev; 2011 Jul; 16(4):411-23. PubMed ID: 20938735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Trends Cardiovasc Med; 2020 Jan; 30(1):11-19. PubMed ID: 30824163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pet Imaging and its Application in Cardiovascular Diseases.
    Li Z; Gupte AA; Zhang A; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2017; 13(1):29-33. PubMed ID: 28413580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted molecular imaging of angiogenesis in PET and SPECT: a review.
    Stacy MR; Maxfield MW; Sinusas AJ
    Yale J Biol Med; 2012 Mar; 85(1):75-86. PubMed ID: 22461745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography imaging in cardiovascular disease.
    Tarkin JM; Ćorović A; Wall C; Gopalan D; Rudd JH
    Heart; 2020 Nov; 106(22):1712-1718. PubMed ID: 32571959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
    Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
    Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical role of positron emission tomography in management of the cardiac patient.
    Pirich C; Schwaiger M
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I89-100. PubMed ID: 10750444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction:
    Aikawa T; Naya M; Obara M; Oyama-Manabe N; Manabe O; Magota K; Ito YM; Katoh C; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1897-1905. PubMed ID: 28653180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac applications of PET.
    Sarikaya I
    Nucl Med Commun; 2015 Oct; 36(10):971-85. PubMed ID: 26035516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in ischemic heart disease.
    Santos BS; Ferreira MJ
    Rev Port Cardiol (Engl Ed); 2019 Aug; 38(8):599-608. PubMed ID: 31694787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study.
    Ekström M; Hellman A; Hasselström J; Hage C; Kahan T; Ugander M; Wallén H; Persson H; Linde C
    ESC Heart Fail; 2020 Apr; 7(2):737-746. PubMed ID: 32073753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Measures of Myocardial Fibrosis in the Transition from Hypertensive Heart Disease to Heart Failure.
    Stacey RB; Hundley WG
    Curr Hypertens Rep; 2021 Apr; 23(4):22. PubMed ID: 33881630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].
    vom Dahl J
    Herz; 1997 Feb; 22(1):1-15. PubMed ID: 9173038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a New
    Moyon A; Garrigue P; Fernandez S; Hubert F; Balasse L; Brige P; Hache G; Nail V; Blot-Chabaud M; Dignat-George F; Rochais F; Guillet B
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.